Preclinical factors affecting the pharmacokinetic behaviour of tanshinone IIA, an investigational new drug isolated from<i>Salvia miltiorrhiza</i>for the treatment of ischaemic heart diseases
Huichang Bi(Southern Medical University), Min Huang(Sun Yat-sen University), Zhengwei Huang(Jinan University), Yajie Wen(Sun Yat-sen University), Ying Deng(Sun Yat-sen University), Zhong Zuo(Chinese University of Hong Kong), Shujun Zhou(RMIT University), Ying Pan, Chen‐shu Xu(Sun Yat-sen University), Lizi Zhao(Sun Yat-sen University), Hai Yan Sun(Sun Yat-sen University), Peng Liu(Sun Yat-sen University), Xi Chen(Sun Yat-sen University), Liqiang Gu(Shenyang Pharmaceutical University)
Cited by 52
Related Papers
Current trends in drug metabolism and pharmacokinetics
|Acta Pharmaceutica Sinica B|2019|391
Photodynamic therapy for cancer: mechanisms, photosensitizers, nanocarriers, and clinical studies
|MedComm|2024|139
SIRT6 as a key event linking P53 and NRF2 counteracts APAP-induced hepatotoxicity through inhibiting oxidative stress and promoting hepatocyte proliferation
|Acta Pharmaceutica Sinica B|2020|129
Optimization of harvesting, extraction, and analytical protocols for UPLC-ESI-MS-based metabolomic analysis of adherent mammalian cancer cells
|Analytical and Bioanalytical Chemistry|2013|126